Quantcast
Last updated on April 21, 2014 at 9:29 EDT

Latest Morphine Stories

2013-05-02 08:37:27

- Additional Phase 3 analysis show significantly faster reduction in pain and fewer patients with oxygen desaturation events for Sufentanil NanoTab PCA System than IV PCA with morphine - REDWOOD CITY, Calif., May 2, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported additional...

2013-04-11 08:28:53

New Implantable Pump Provides Important New Options for Physicians Treating Chronic Pain Patients MOUNT OLIVE, N.J., April 11, 2013 /PRNewswire/ -- Flowonix Medical Inc., a medical device company focused on providing advanced implantable drug delivery solutions, announced today the US launch of the Prometra programmable intrathecal pump. The Prometra pump provides important new enhancements for physicians who treat patients in chronic pain through the delivery of preservative-free...

2013-04-02 23:02:33

Overdose deaths from prescription painkillers have more than tripled over the last decade; according to a Policy Impact Report from the CDC, nearly three out of four prescription drug overdoses are caused by prescription painkillers; millions of people report using prescription painkillers nonmedically and, the dangers of overdose death are gloomy. Pure Health Group Inc. reacts to this and reveals a different solution; their unique at home detox system to help get this epidemic under...

2013-03-28 23:00:13

Prescription Painkiller overdose has taken over our country according to a February 8th CBS Evening News Report with Scott Pelley; millions of individuals are afflicted with an addiction to prescription painkillers. Overdose from pain pills is a leading cause of death in the US; Pure Health Group Inc. comments and offers an at home detox system to help get people off painkillers once and for all. DENVER, COLORADO (PRWEB) March 28, 2013 Prescription Painkiller overdose has taken over our...

2013-03-12 16:24:05

REDWOOD CITY, Calif., March 12, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported financial results for the fourth quarter and year ended December 31, 2012, and provided a corporate update. (Logo: http://photos.prnewswire.com/prnh/20130226/MM67303LOGO) "We made important strides in the...

2013-03-04 12:28:46

Relmada Therapeutics announces the approval of its CTA (Clinical Trial Authorization) by the MHRA (Medicines and Healthcare products Regulatory Agency) in the United Kingdom to conduct a Phase 1 pharmacokinetic study with LevoCap ER. BLUE BELL, Pa., March 4, 2013 /PRNewswire/ -- Relmada Therapeutics, Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced the approval of the application of a Clinical Trial Authorization (CTA) that...

2013-02-28 08:31:04

Successful NDA Review to Position Product for Approval in Q3 2013 SYDNEY and BEDMINSTER, N.J., Feb. 28, 2013 /PRNewswire/ -- QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the Company resubmitted its MOXDUO(® )New Drug Application (NDA). As disclosed on 16 January 2013, at its last meeting with the Company, the US Food and Drug Administration (FDA) requested the resubmission of the NDA to include the respiratory safety results of Study 022. "We believe the...

2013-02-14 12:25:14

NORTH LIBERTY, Iowa, Feb. 14, 2013 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, offered its support for the recent Food and Drug Administration (FDA) recommendations to curtail the potential abuse of opioid-based therapeutics. In two separate actions, on January 25, 2013, the FDA's Drug Safety and Risk Management Advisory Committee (DSaRM) voted in favor of reclassifying...

2013-02-13 23:02:01

Five Points Wellness and Recovery: A 12-Month Bio-Psycho-Social Intensive Outpatient Treatment Program Utilizing Suboxone, Psychotherapy, Wellness and Occupational Support Mequon, Wisconsin (PRWEB) February 13, 2013 Each day millions of people suffer from the devastating cycle of opiate addiction. The impact of opiate addiction extends far beyond the ravages on the body. The ramifications of opiate addiction causes job loss, failed relationships, a disregard for one´s physical...

2013-02-04 12:25:50

BEVERLY HILLS, Calif., Feb. 4, 2013 /PRNewswire/ -- Following recommendations from an advisory panel to the United States Food and Drug Administration (FDA) proposing tighter restrictions on hydrocodone drugs, for example Vicodin, Norco and Lortab, Clare Waismann, registered addiction specialist and administrative director for the WAISMANN METHOD® opiate treatment, is urging doctors nationwide to practice restraint in prescribing these medications due to their highly-addictive chemical...